Page 3 - Thomasf Gajewski News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomasf gajewski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomasf Gajewski Today - Breaking & Trending Today

Brokerages Set Jounce Therapeutics, Inc. (NASDAQ:JNCE) Target Price at $8.00

Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) has received a consensus rating of “Hold” from the six ratings firms that are covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1-year price target among brokers that […] ....

United Kingdom , Jamesp Allison , Raymond James , Padmanee Sharma , Thomasf Gajewski , Kevinc Tang , Louism Weiner , Robert Schreiber , Piper Sandler , Sumitomo Mitsui Financial Group , Investment Advisers , Capital Management , Health Sciences , Wealth Group , Jounce Therapeutics Inc , Jounce Therapeutics Company Profile , Balyasny Asset Management , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Director Richard , Asset Management , Jounce Therapeutics Daily , Nasdaq Jnce ,

Susquehanna International Group LLP Purchases 26,125 Shares of Jounce Therapeutics, Inc. (NASDAQ:JNCE)

Susquehanna International Group LLP boosted its position in Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) by 824.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 29,292 shares of the company’s stock after buying an additional 26,125 shares during the period. Susquehanna International Group LLP’s holdings in Jounce Therapeutics were worth $33,000 as of its […] ....

United Kingdom General , United Kingdom , United States , Jamesp Allison , Louism Weiner , Kevinc Tang , Raymond James , Piper Sandler , Thomasf Gajewski , Padmanee Sharma , Robert Schreiber , Citadel Advisors , Health Sciences , Jounce Therapeutics Company Profile , Exchange Commission , Jounce Therapeutics Inc , Securities Exchange Commission , Sumitomo Mitsui Financial Group , Susquehanna International Group , Blackrock Inc , America Corp , Jounce Therapeutics , Get Rating , International Group , Mitsui Financial Group , Director Richard ,

Jounce Therapeutics (NASDAQ:JNCE) Now Covered by StockNews.com

StockNews.com began coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research note published on Saturday. The brokerage issued a hold rating on the stock. JNCE has been the subject of several other reports. Sumitomo Mitsui Financial Group reissued a neutral rating on shares of Jounce Therapeutics in a research report on […] ....

United Kingdom , Thomasf Gajewski , Jamesp Allison , Piper Sandler , Padmanee Sharma , Kevinc Tang , Raymond James , Louism Weiner , Robert Schreiber , Jounce Therapeutics Inc , Jounce Therapeutics Company Profile , Millennium Management , Securities Exchange Commission , Capital Management , Voya Investment Management , Sumitomo Mitsui Financial Group , Squarepoint Ops , Investment Advisers , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Exchange Commission , Director Richard , Investment Management , Jounce Therapeutics Daily , Nasdaq Jnce ,

Jounce Therapeutics, Inc. (NASDAQ:JNCE) Receives Average Rating of "Hold" from Analysts

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....

United Kingdom , United States , Thomasf Gajewski , Kevinc Tang , Raymond James , Jamesp Allison , Piper Sandler , Robert Schreiber , Louism Weiner , Padmanee Sharma , Securities Exchange Commission , Jounce Therapeutics Company Profile , Jounce Therapeutics Inc , America Corp , Sumitomo Mitsui Financial Group , Capital Management , Millennium Management , Jounce Therapeutics , Get Rating , Marketbeat Ratings , Mitsui Financial Group , Exchange Commission , Director Richard , Jounce Therapeutics Daily ,

Jounce Therapeutics, Inc. (NASDAQ:JNCE) Sees Large Decrease in Short Interest

Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 2,280,000 shares, a drop of 28.3% from the March 15th total of 3,180,000 shares. Approximately 5.2% of the shares of the stock are short sold. Based on an average daily […] ....

United States , United Kingdom , Piper Sandler , Padmanee Sharma , Robert Schreiber , Thomasf Gajewski , Louism Weiner , Raymond James , Kevinc Tang , Jamesp Allison , Jounce Therapeutics Company Profile , Principal Financial Group Inc , Securities Exchange Commission , Jounce Therapeutics Inc , American International Group Inc , Silverarc Capital Management , Cubist Systematic Strategies , Sumitomo Mitsui Financial Group , Jounce Therapeutics , Get Rating , Exchange Commission , Director Richard , Capital Management , International Group , Financial Group , Systematic Strategies ,